PharmaTutor (February- 2014)
ISSN: 2347 - 7881
Received On: 26/12/2013; Accepted On: 02/01/2014; Published On: 10/02/2014
Author: Harsh Vyas, Tulsi Upadhyay, Nirali Thakkar, Kruti Patel, Umesh Upadhyay
Sigma Institute of Pharmacy,
Bakrol, Vadodara, Gujarat, India
*vyas123harsh@gmail.com
ABSTRACT: Nanocochleate is a novel lipid based drug delivery system offering systemic and oral delivery of various charged drug molecules. It is formed by negatively charged lipid bilayer. Nanocochleate can encapsulate drugs which are hydrophobic, positively charged, negatively charged and poor orally bioavailable. It is also very much beneficial for oral absorption for peptide drugs that possess a net positive charge. Nanocochleate is beneficial for molecules having binding sites inside the cell. The property that nanocochleates can facilitate cross membrane diffusion for charged and impermeable molecules finds wide application in drug delivery. Nanocochleate have been proven better than liposomes and more compatible with body environment. They differ from liposomes by its structure and compatibility to the body. Liposomes are lipid bilayer with aqueous inner environment and unlike liposomes nanocochleates are having charged lipid bilayer without aqueous environment and are multilayer lipid matrix i.e. Cochleate.
Various methods of its formulation, structure, merits demerits and wide range of application are described in this article.
How to cite this article: H Vyas, T Upadhyay, N Thakkar, K Patel, U Upadhyay, Nanocochleate: Novel Bypass of Conventional Drug Delivery System, PharmaTutor, 2014, 2(2), 90-97
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1. Gregoriadis G, in Liposome Technology, CRC Press,Boca Raton, vol. I, 1993.
2. Popescu C, franzblau S, zarif L. Cochleates Potentiate the Efficacy of Antibacterial Drug, Clofazimine. Abstract presented at 41st icaac december 16?19, 2001, in Chicago.
3. Ramasamy T, Khandasamy U, Hinabindhu R, Kona K. Nanocochleate – A New Drug Delivery System. Fabad j. Pharm. Sci., 2009;3: 91–101
4. Zarif L, Graybill J, Perlin D, Mannino Rj. Cochleates: New Lipid Based Drug Delivery System. J liposome res, 2000; 10: 523-538.
5. Panwar V, Mahajan V, Panwar A, Darwhekar G, Jain D. Nanocochleate: As Drug Delivery Vehicle. Int J pharm and biological sci, 2011; 1(1):32-38.
6. Zarifll, Graybill J, Perlin D, Et Al. Antifungal Activity Of Amphotericin B Cochleates Against Candida Albicans Infection In A Mouse Model. Antimicrob agents’ chemother, 2000; 44: 1463.
7. Segarra I, Movshin Da, Zarif L. Pharmacokinetics And Tissue Distribution After Intravenous Administration Of A Single Dose Of Amphotericin B Cochleates, A New Lipid-Based Delivery System. J pharm sci, 2002; 91: 1827.
8. Gould-Fogerite S & Mannino R. (1997). Cochleate delivery vehicles, U.S. Patent 5,994,318
9. Zarif, L, & Perlin D. Amphotericin B Nanocochleates: From Formulation To Oral Efficacy, Drug Delivery Technology, 2002; 2(4): 34-37.
10. Ravi Sankar V, Reddy Y. Nanocochleate – A New Approach in Lipid Drug Delivery. Int J pharm and pharm sci,2010;2(4):221-223
11. Development of a Nanocochleate Based Apoa1 Formulation for the Treatment of Atherosclerosis And Other Coronary Heart Diseases. Available at pharmaceutical practical guide, indigo pharma.
12. Villa A, Caporizzo E, Papagni A. Choline And Phosphatidylcholine Fluorescent Derivatives Localization In Carcinoma Cells Studied By Laser Scanning Confocal Fluorescence Microscopy. Eur. J. Cancer, 2005; 41: 1453–1459.
13. Mannino J, Gould-Fogerite S, Krause-Elsmore L, Delmarre D, Lu R.(2005) Novel Encochleation Methods, Cochleates And Methods Of Use, U.S. Patent application 2005/0013854 a1
.png)
